razoxane has been researched along with EHS Tumor in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, RW; Grimshaw, MB; Hall, WS | 1 |
Casazza, AM; Di Marco, A; Giuliani, F; Savi, G | 1 |
Baba, H; Bull, JM; Newman, RA; Ohno, S; Siddik, ZH; Stephens, LC; Strebel, FR | 1 |
Green, MD; Muggia, FM; Wadler, S | 1 |
4 other study(ies) available for razoxane and EHS Tumor
Article | Year |
---|---|
Combination therapy of a mouse sarcoma using razoxane and electron irradiation.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Male; Mice; Oxygen Consumption; Piperazines; Razoxane; Sarcoma, Experimental | 1981 |
Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in mice.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Razoxane; Sarcoma, Experimental; Time Factors; Transplantation, Isogeneic | 1979 |
Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
Topics: Animals; Blood Cell Count; Body Weight; Combined Modality Therapy; Doxorubicin; Female; Heart Diseases; Hematopoiesis; Hyperthermia, Induced; Kidney Diseases; Nervous System Diseases; Rats; Rats, Inbred F344; Razoxane; Sarcoma, Experimental; Survival Analysis | 1991 |
Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line.
Topics: Animals; Cell Cycle; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Synergism; Mice; Neoplastic Stem Cells; Piperazines; Razoxane; Sarcoma, Experimental | 1986 |